CLINICAL_TRIALS
trial_result
· 2022-04-15
Clinical Trial Update: Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART [Phase 2]
Summary
Phase 2 trial update evaluating eltrombopag for patients with prolonged bone marrow toxicity after CAR-T therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: CART Treatment, B Cell Lymphoma | Phase 2 | Status: UNKNOWN